Chung Jane is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $10K.
Profile
Jane Chung is the President and Chief Operating Officer of Sutro Biopharma, Inc., a clinical-stage biopharmaceutical company focused on developing protein therapeutics for cancer and autoimmune disorders. She has played a significant role in the company's strategic direction and operational management.
Role
Insider
Notability
50/100
Board memberships
Sutro Biopharma, Inc.
Awards & honors
Leadership in clinical-stage drug development
Oversight of biopharmaceutical product manufacturing
Jane Chung is the President and Chief Operating Officer of Sutro Biopharma, Inc., a clinical-stage biopharmaceutical company focused on developing protein therapeutics for cancer and autoimmune disorders. She has played a significant role in the company's strategic direction and operational management.…
Has Chung Jane been buying or selling stock?
Recorded transactions: 1 open-market purchases ($10K) and 0 open-market sales () across all tracked filings.
Where can I see all of Chung Jane's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
